Literature DB >> 16504406

Macrophage migration inhibitory factor induces cell death and decreases neuronal nitric oxide expression in spinal cord neurons.

M Chalimoniuk1, K King-Pospisil, C N Metz, M Toborek.   

Abstract

Macrophage migration inhibitory factor is a potent proinflammatory cytokine; however, its role in spinal cord injury is poorly understood. Therefore, the aim of the present study was to investigate the effects of macrophage migration inhibitory factor on spinal cord neuron survival and viability. Due to the importance of nitric oxide metabolism in these events, part of our study was also focused on the influence of recombinant macrophage migration inhibitory factor on neuronal nitric oxide expression. Exposure of cultured mouse spinal cord neurons to macrophage migration inhibitory factor markedly increased cellular oxidative stress as measured by 2',7'-dichlorofluorescein fluorescence and intracellular calcium levels. In addition, an antagonist of the inositol 1,4,5-triphosphate receptor, 8-(diethylamino)octyl 3,4,5-trimethoxybenzoate, completely blocked the macrophage migration inhibitory factor-induced increase in intracellular calcium levels. Macrophage migration inhibitory factor treatment also decreased cell viability, increased cellular lactate dehydrogenase release, and induced chromatin condensation and aggregation in cultured spinal cord neurons. Finally, exposure to macrophage migration inhibitory factor markedly decreased expression and activity of neuronal nitric oxide, accompanied by a decrease in cellular guanosine 3'5'-cyclic monophosphate levels. The present results indicate that macrophage migration inhibitory factor can induce dysfunction of spinal cord neurons, leading to cell death through oxidative stress and intracellular calcium-dependent pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16504406     DOI: 10.1016/j.neuroscience.2005.12.056

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  10 in total

1.  AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS.

Authors:  Marcel F Leyton-Jaimes; Joy Kahn; Adrian Israelson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-01       Impact factor: 11.205

Review 2.  Macrophage migration inhibitory factor as a therapeutic target after traumatic spinal cord injury: a systematic review.

Authors:  Seyed Mohammad Piri; Zahra Ghodsi; Sina Shool; Ali Anjomshoa; Amir Azarhomayoun; Ehsan Jangholi; Hamid Reza Dehghan; Rasha Atlasi; Alexander R Vaccaro; Vafa Rahimi-Movaghar
Journal:  Eur Spine J       Date:  2021-01-24       Impact factor: 3.134

3.  Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice.

Authors:  Jinbo Cheng; Yajin Liao; Yuan Dong; Han Hu; Nannan Yang; Xiangxi Kong; Shuoshuo Li; Xiaoheng Li; Jifeng Guo; Lixia Qin; Jiezhong Yu; Cungen Ma; Jianke Li; Mingtao Li; Beisha Tang; Zengqiang Yuan
Journal:  Autophagy       Date:  2020-01-31       Impact factor: 16.016

4.  Thrombin acts as inducer of proinflammatory macrophage migration inhibitory factor in astrocytes following rat spinal cord injury.

Authors:  Ting Yang; Haiyan Jiang; Xinye Luo; Yuxuan Hou; Aicheng Li; Bingqiang He; Xingyuan Zhang; Huifei Hao; Honghua Song; Rixin Cai; Xudong Wang; Yingjie Wang; Chun Yao; Lei Qi; Yongjun Wang
Journal:  J Neuroinflammation       Date:  2022-05-27       Impact factor: 9.587

5.  Macrophage migration inhibitory factor acts as a neurotrophin in the developing inner ear.

Authors:  Lisa M Bank; Lynne M Bianchi; Fumi Ebisu; Dov Lerman-Sinkoff; Elizabeth C Smiley; Yu-chi Shen; Poornapriya Ramamurthy; Deborah L Thompson; Therese M Roth; Christine R Beck; Matthew Flynn; Ryan S Teller; Luming Feng; G Nicholas Llewellyn; Brandon Holmes; Cyrrene Sharples; Jaeda Coutinho-Budd; Stephanie A Linn; Andrew P Chervenak; David F Dolan; Jennifer Benson; Ariane Kanicki; Catherine A Martin; Richard Altschuler; Alisa E Koch; Alicia E Koch; Ethan M Jewett; John A Germiller; Kate F Barald
Journal:  Development       Date:  2012-12       Impact factor: 6.868

6.  Macrophage migration inhibitory factor activates inflammatory responses of astrocytes through interaction with CD74 receptor.

Authors:  Yu Su; Yingjie Wang; Yue Zhou; Zhenjie Zhu; Qing Zhang; Xuejie Zhang; Wenjuan Wang; Xiaosong Gu; Aisong Guo; Yongjun Wang
Journal:  Oncotarget       Date:  2017-01-10

7.  Altered Circulating Immune Cell Distribution in Traumatic Spinal Cord Injury Patients in Relation to Clinical Parameters.

Authors:  Judith Fraussen; Lien Beckers; Charlotte C M van Laake-Geelen; Bart Depreitere; Jens Deckers; Erwin M J Cornips; Dieter Peuskens; Veerle Somers
Journal:  Front Immunol       Date:  2022-06-28       Impact factor: 8.786

Review 8.  Macrophage polarization: a key event in the secondary phase of acute spinal cord injury.

Authors:  Xiangyi Kong; Jun Gao
Journal:  J Cell Mol Med       Date:  2016-12-13       Impact factor: 5.310

9.  Macrophage migration inhibitory factor facilitates production of CCL5 in astrocytes following rat spinal cord injury.

Authors:  Yue Zhou; Wei Guo; Zhenjie Zhu; Yuming Hu; Yingjie Wang; Xuejie Zhang; Wenjuan Wang; Nan Du; Tiancheng Song; Kaini Yang; Zongyu Guan; Yongjun Wang; Aisong Guo
Journal:  J Neuroinflammation       Date:  2018-09-04       Impact factor: 8.322

10.  CCL3 contributes to secondary damage after spinal cord injury.

Authors:  Nicolas Pelisch; Jose Rosas Almanza; Kyle E Stehlik; Brandy V Aperi; Antje Kroner
Journal:  J Neuroinflammation       Date:  2020-11-27       Impact factor: 8.322

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.